We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current AKAN market cap is 2.2M. The company's latest EPS is USD -6.0819 and P/E is -0.19.
Quarter End | ||
---|---|---|
USD ($) | USD ($) | |
Total Revenue | ||
Operating Income | ||
Net Income |
Year End December 30 2022 | 2021 | 2022 |
---|---|---|
USD ($) | USD ($) | |
Total Revenue | 41k | 3.87M |
Operating Income | -4.26M | -15.72M |
Net Income | -8.13M | -11.66M |
Quarter End | ||
---|---|---|
USD ($) | USD ($) | |
Total Assets | ||
Total Liabilities | ||
Total Equity |
Year End December 30 2022 | 2021 | 2022 |
---|---|---|
USD ($) | USD ($) | |
Total Assets | 8.05M | 39M |
Total Liabilities | 10.25M | 12.1M |
Total Equity | -2.2M | 26.9M |
Market Cap | 2.2M |
Price to Earnings Ratio | -0.19 |
Price to Sales Ratio | 0.57 |
Price to Cash Ratio | 8.61 |
Price to Book Ratio | 0.08 |
Dividend Yield | - |
Shares Outstanding | 1.92M |
Average Volume (1 week) | 49.16k |
Average Volume (1 Month) | 606.53k |
52 Week Change | -99.99% |
52 Week High | 12,400.00 |
52 Week Low | 1.035 |
Spread (Intraday) | 0.02 (1.74%) |
Company Name | Akanda Corporation |
Address |
77 king street west suite 400 toronto, ontario M5K 0A1 |
Website | https://akandacorp.com/ |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions